Back

A patient with HF and LVEF > 40%: neurohumoral modulators.

27 August 2022 (11:15 - 11:30)
Organised by:
Congress Presentation Part of: How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40% Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
A patient with HF and LVEF > 40%: SGLT2 inhibitors.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
A patient with HF and LVEF > 40%: exercise training.
Professor E. Van Craenenbroeck (Edegem, BE)
Slides Video
Presentation thumbnail
Putting it all together: what to do for a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%.
Professor M. Jessup (Dallas, US)
Slides Video

Access the full session

Session thumbnail
How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET
You may be interested in
thumbnail
Webinar
Most recent updates for treating heart failure. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Webinar
Management of heart failure with preserved ejection fraction. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Webinar
HFpEF: a dilemma in the diagnosis of a treatable disease!

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources